From the BBC site in the Last hour

++
Johnson & Johnson says it's going to delay the rollout of its vaccine in Europe, and is reviewing cases of extremely rare blood clots in a small number of people who've received the jab.

US health officials earlier called for a pause on Johnson & Johnson's single-dose vaccinations, after six people there developed a rare disorder involving blood clots.
++